These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33584322)

  • 81. The goal of geroscience is life extension.
    Blagosklonny MV
    Oncotarget; 2021 Feb; 12(3):131-144. PubMed ID: 33613842
    [TBL] [Abstract][Full Text] [Related]  

  • 82. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner.
    Meeran MFN; Laham F; Azimullah S; Sharma C; Al Kaabi AJ; Tariq S; Adeghate E; Goyal SN; Ojha S
    Free Radic Biol Med; 2021 May; 167():348-366. PubMed ID: 33588052
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The kinase PDK1 is critical for promoting T follicular helper cell differentiation.
    Sun Z; Yao Y; You M; Liu J; Guo W; Qi Z; Wang Z; Wang F; Yuan W; Yu S
    Elife; 2021 Feb; 10():. PubMed ID: 33595435
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Imaging of Oncologic Treatment-Related Pneumonitis: A Focused Review on Emerging Issues of Immune Checkpoint Inhibitor Pneumonitis, From the
    Nishino M
    AJR Am J Roentgenol; 2022 Jan; 218(1):19-27. PubMed ID: 33594904
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.
    Lehrer S; Rheinstein PH
    Discov Med; 2020; 30(161):163-171. PubMed ID: 33593484
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Long-term progression-free survival in a patient with advanced non-small-cell lung cancer treated with low-dose gefitinib and traditional herbal medicine: A case report.
    Lee BJ; Kim KI; Choi CW; Kim JY; Lee JH
    Medicine (Baltimore); 2021 Feb; 100(5):e24292. PubMed ID: 33592873
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hallmarks of the aging T-cell system.
    Zhang H; Weyand CM; Goronzy JJ
    FEBS J; 2021 Dec; 288(24):7123-7142. PubMed ID: 33590946
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.
    Robichaud S; Fairman G; Vijithakumar V; Mak E; Cook DP; Pelletier AR; Huard S; Vanderhyden BC; Figeys D; Lavallée-Adam M; Baetz K; Ouimet M
    Autophagy; 2021 Nov; 17(11):3671-3689. PubMed ID: 33590792
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mechanisms underlying reproductive toxicity induced by nickel nanoparticles identified by comprehensive gene expression analysis in GC-1 spg cells.
    Kong L; Wu Y; Hu W; Liu L; Xue Y; Liang G
    Environ Pollut; 2021 Apr; 275():116556. PubMed ID: 33588191
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.
    Vidal L; Victoria I; Gaba L; Martín MG; Brunet M; Colom H; Cortal M; Gómez-Ferrería M; Yeste-Velasco M; Perez A; Rodon J; Sohal DPS; Lizcano JM; Domènech C; Alfón J; Gascón P
    Eur J Cancer; 2021 Mar; 146():87-94. PubMed ID: 33588149
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Decoding the Evolutionary Response to Ensartinib in Patients With ALK-Positive NSCLC by Dynamic Circulating Tumor DNA Sequencing.
    Yang Y; Huang J; Wang T; Zhou J; Zheng J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Mao L; Selvaggi G; Zhu L; Xiao S; Yuan X; Shen Z; Zhang L
    J Thorac Oncol; 2021 May; 16(5):827-839. PubMed ID: 33588113
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
    Aredo JV; Mambetsariev I; Hellyer JA; Amini A; Neal JW; Padda SK; McCoach CE; Riess JW; Cabebe EC; Naidoo J; Abuali T; Salgia R; Loo BW; Diehn M; Han SS; Wakelee HA
    J Thorac Oncol; 2021 Jun; 16(6):1030-1041. PubMed ID: 33588109
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Loganin Attenuates Septic Acute Renal Injury with the Participation of AKT and Nrf2/HO-1 Signaling Pathways.
    Zhang J; Wang C; Kang K; Liu H; Liu X; Jia X; Yu K
    Drug Des Devel Ther; 2021; 15():501-513. PubMed ID: 33603340
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass.
    Tokuchi Y; Suda G; Kimura M; Maehara O; Kitagataya T; Ohara M; Yamada R; Shigesawa T; Suzuki K; Kawagishi N; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
    J Viral Hepat; 2021 May; 28(5):755-763. PubMed ID: 33587828
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Proliferation of MDA-MB-231 can be suppressed by dimeric-epigallocatechin gallate through competitive inhibition of amphiregulin-epidermal growth factor receptor signaling.
    Huang Y; Zhang X; Pang Q; Zhu Q; Liang Q; Zi C; Zhang D; Xiang Z; Wang X; Sheng J
    Anticancer Drugs; 2021 Jun; 32(6):647-656. PubMed ID: 33587351
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
    Nso N; Bookani KR; Enoru ST; Radparvar F; Gordon R
    Heart Fail Rev; 2022 May; 27(3):811-820. PubMed ID: 33587248
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutation.
    Nishimura T; Okano T; Naito M; Iwanaka S; Ohiwa A; Sakakura Y; Yasuma T; Fujimoto H; D'Alessandro-Gabazza CN; Oomoto Y; Kobayashi T; Gabazza EC; Ibata H
    Thorac Cancer; 2021 Apr; 12(7):1067-1073. PubMed ID: 33586356
    [TBL] [Abstract][Full Text] [Related]  

  • 98. EphA2 promotes tumorigenicity of cervical cancer by up-regulating CDK6.
    Huang C; Chen Z; He Y; He Z; Ban Z; Zhu Y; Ding L; Yang C; Jeong JH; Yuan W; Yang L
    J Cell Mol Med; 2021 Mar; 25(6):2967-2975. PubMed ID: 33586348
    [TBL] [Abstract][Full Text] [Related]  

  • 99. mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate.
    Fernandes H; Moura J; Carvalho E
    Stem Cell Rev Rep; 2021 Aug; 17(4):1312-1322. PubMed ID: 33586059
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling Pathway.
    Sui X; Han X; Chen P; Wu Q; Feng J; Duan T; Chen X; Pan T; Yan L; Jin T; Xiang Y; Gao Q; Wen C; Ma W; Liu W; Zhang R; Chen B; Zhang M; Yang Z; Kong N; Xie T; Ding X
    Front Mol Biosci; 2020; 7():602282. PubMed ID: 33585556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.